December 2, 2014—Two members of Congress who have been investigating rising generic drug prices have introduced legislation that would require generic drugmakers to provide larger Medicaid drug rebates whenever their products’ prices rise faster than the rate of inflation.
You must be registered to read complete articles (it's quick, easy, and 100% free). Click here to register. Already registered? Click here to login. (340B Health members, Drug Discount Monitor subscribers, and 340B Coalition conference attendees: Use your existing username and password.)